124414-07-9

Basic information

• Product Name: Ethanone, 1-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-
• CAS NO: 124414-07-9
• Molecular Formula: C14H22O2Si
• Molecular Weight: 250.413
• Mol File: 124414-07-9.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-(124414-07-9)
• EPA Substance Registry System: Ethanone, 1-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-(124414-07-9)

Safety Data

• Hazardous Substances Data: 124414-07-9(Hazardous Substances Data)

Upstream product

• 121-71-1 3-Hydroxyacetophenone 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 124425-53-2 tert-Butyl-[3-(1,1-dimethoxy-ethyl)-phenoxy]-dimethyl-silane 

Downstream Products

• 681275-04-7 1-(3'-t-butyldimethylsilyloxyphenyl)ethanol 
• 268233-77-8 ethyl 3-[3-(tert-butyldimethylsilanyloxy)phenyl]-butyrate 
• 1170699-62-3 (E)-N-{1-[3-(tert-butyldimethylsilyloxy)phenyl]ethylidene}-4-methoxyaniline 
• 150731-24-1 tert-butyl dimethyl(3-(prop-1-en-2-yl)phenoxy)silane 
• 191729-33-6 C₁₇H₂₇NO₂Si 
• 1426074-89-6 (5-hydroxybenzofuran-3yl) (3-hydroxyphenyl)methanone 
• 1424343-31-6 2-(3-((tert-butyldimethylsilyl)oxy)phenyl)propanal 

Relevant articles and documents

Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding

We recently characterized a series of novel platinum(II) compounds bearing a conserved O,S binding moiety as a bifunctional ligand and evaluated their solution behavior and antiproliferative properties in vitro against a representative cancer cell line. O

Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance

We report on platinum(ii) complexes with different cinnamic acid derivatives as ligands with cytotoxic activity against Cisplatin resistant ovarian cancer cell line subcultures of SKOV3 and A2780. A typical mechanism of action for platinum(ii) complexes a

HCV POLYMERASE INHIBITORS

The invention provides compounds of the formula:(I) wherein B is a nucleobase selected from the groups (a) to (d) and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.